SI1632232T1 - Sol 4((4((4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)amino) benzonitrila - Google Patents

Sol 4((4((4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)amino) benzonitrila

Info

Publication number
SI1632232T1
SI1632232T1 SI200531339T SI200531339T SI1632232T1 SI 1632232 T1 SI1632232 T1 SI 1632232T1 SI 200531339 T SI200531339 T SI 200531339T SI 200531339 T SI200531339 T SI 200531339T SI 1632232 T1 SI1632232 T1 SI 1632232T1
Authority
SI
Slovenia
Prior art keywords
åamino
cyanoethenyl
dimethylphenyl
pyrimidinyl
salt
Prior art date
Application number
SI200531339T
Other languages
English (en)
Inventor
Paul Theodoor Agnes Stevens
Jozef Peeters
Roger Petrus Gerebern Vandecruys
Alfred Elisabeth Stappers
Alex Herman Copmans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38091637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1632232(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from MYPI20043578A external-priority patent/MY169670A/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SI1632232T1 publication Critical patent/SI1632232T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
SI200531339T 2004-09-02 2005-09-02 Sol 4((4((4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)amino) benzonitrila SI1632232T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
MYPI20043578A MY169670A (en) 2003-09-03 2004-09-02 Combinations of a pyrimidine containing nnrti with rt inhibitors
PCT/EP2004/052028 WO2005021001A1 (en) 2003-09-03 2004-09-03 Combinations of a pyrimidine containing nnrti with rt inhibitors
EP05101467 2005-02-25
EP05108086.9A EP1632232B3 (en) 2004-09-02 2005-09-02 Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile

Publications (1)

Publication Number Publication Date
SI1632232T1 true SI1632232T1 (sl) 2011-09-30

Family

ID=38091637

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531339T SI1632232T1 (sl) 2004-09-02 2005-09-02 Sol 4((4((4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)amino) benzonitrila

Country Status (21)

Country Link
EP (1) EP1632232B3 (sl)
JP (1) JP4912309B2 (sl)
CN (1) CN104586850A (sl)
AT (1) ATE508748T1 (sl)
BR (1) BRPI0514871A (sl)
CY (3) CY1112249T1 (sl)
DK (1) DK1632232T6 (sl)
EA (1) EA013686B1 (sl)
ES (1) ES2371442T7 (sl)
FR (2) FR16C1025I1 (sl)
HK (1) HK1210029A1 (sl)
HU (2) HUS1600060I1 (sl)
IL (1) IL181650A (sl)
LT (2) LTPA2016043I1 (sl)
ME (1) ME01246B (sl)
MX (1) MX2007002595A (sl)
NI (1) NI200700068A (sl)
NO (3) NO340654B1 (sl)
PT (1) PT1632232E (sl)
RS (1) RS51923B2 (sl)
SI (1) SI1632232T1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
KR101501475B1 (ko) * 2006-01-20 2015-03-19 얀센 알 앤드 디 아일랜드 Ｔｍｃ２７８을 이용한 ｈｉｖ 감염의 장기간 요법
CL2008000746A1 (es) 2007-03-14 2008-09-22 Tibotec Pharm Ltd Composicion farmaceutica en solucion que comprende tmc278 y un polimero soluble en agua; proceso de preparacion de dicha composicion; y uso de un polvo que comprende tmc278 para tratar sida.
MX347512B (es) 2010-11-19 2017-04-28 Gilead Sciences Inc Composiciones terapeuticas que comprenden hcl de rilpivirina y fumarato de disoproxilo de tenofovir.
US8952155B2 (en) * 2011-04-15 2015-02-10 Emcure Pharmaceuticals Limited Rilpivirine process
EP2628732A1 (en) * 2012-02-20 2013-08-21 Sandoz AG Novel crystalline form of rilpivirine hydrochloride
EP2604593A1 (en) 2011-12-14 2013-06-19 Sandoz AG Polymorph of Rilpivirine hydrochloride and its use as antiviral
WO2013087794A1 (en) 2011-12-14 2013-06-20 Sandoz Ag Polymorph of rilpivirine hydrochloride and its use as antiviral
WO2013153162A1 (en) * 2012-04-11 2013-10-17 Sandoz Ag Polymorph of rilpivirine hydrochloride
WO2013153161A2 (en) * 2012-04-11 2013-10-17 Sandoz Ag Novel polymorph of rilpivirine hydrochloride
CN103570688B (zh) * 2012-07-19 2016-06-08 中国科学院上海药物研究所 2，5-二氨甲基吡嗪类化合物、其药物组合物、制备方法和用途
GR1008965B (el) * 2015-12-02 2017-02-28 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο σκευασμα που περιλαμβανει δαρουναβιρη και μεθοδος παρασκευης αυτου
RU2616267C1 (ru) * 2016-01-25 2017-04-13 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма индинавира немедленного высвобождения и способ ее получения
RU2019115672A (ru) * 2016-10-24 2020-11-24 Янссен Сайенсиз Айрлэнд Анлимитед Компани Диспергируемые композиции
CN114392241B (zh) * 2022-01-10 2023-07-25 安徽贝克生物制药有限公司 一种利匹韦林片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307543B1 (en) * 1998-09-10 2001-10-23 Silicon Image, Inc. Bi-directional data transfer using two pair of differential lines as a single additional differential pair
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
KR101140785B1 (ko) * 2002-08-09 2012-05-03 얀센 파마슈티카 엔.브이. 4-〔〔4-〔〔4-（2-시아노에테닐）-2,6-디메틸페닐〕아미노〕-2-피리미디닐〕아미노〕벤조니트릴의 제조방법
WO2004050068A1 (en) * 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
EA011164B1 (ru) * 2003-02-07 2009-02-27 Янссен Фармацевтика Н. В. Производные пиримидина для профилактики вич-инфекции

Also Published As

Publication number Publication date
BRPI0514871A (pt) 2008-06-24
JP2008511592A (ja) 2008-04-17
FR16C1025I1 (fr) 2017-02-03
ME01246B (me) 2013-06-20
CY2016051I1 (el) 2017-07-12
NO340654B1 (no) 2017-05-22
PT1632232E (pt) 2011-08-02
DK1632232T6 (da) 2022-04-19
CN104586850A (zh) 2015-05-06
IL181650A (en) 2012-08-30
EA013686B1 (ru) 2010-06-30
RS51923B2 (sr) 2022-05-31
ATE508748T1 (de) 2011-05-15
RS51923B (en) 2012-02-29
FR16C1023I1 (fr) 2017-02-03
IL181650A0 (en) 2007-07-04
LTPA2016043I1 (lt) 2017-01-10
ES2371442T7 (es) 2022-05-12
NO2017065I1 (no) 2017-11-21
EA200700536A1 (ru) 2007-08-31
LTPA2016042I1 (lt) 2017-01-10
JP4912309B2 (ja) 2012-04-11
HUS1600060I1 (hu) 2017-01-30
HK1210029A1 (en) 2016-04-15
NO20071745L (no) 2007-04-02
MX2007002595A (es) 2007-04-25
NI200700068A (es) 2016-09-29
EP1632232B3 (en) 2022-03-30
HUS1600061I1 (hu) 2017-01-30
NO2017063I1 (no) 2017-11-21
CY1112249T1 (el) 2015-12-09
EP1632232B1 (en) 2011-05-11
DK1632232T3 (da) 2011-08-22
CY2016050I1 (el) 2017-07-12
EP1632232A1 (en) 2006-03-08
ES2371442T3 (es) 2012-01-02

Similar Documents

Publication Publication Date Title
HUS1600060I1 (hu) 4[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]-2-pirimidinil]amino]benzonitril
HK1174922A1 (en) Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6- dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile 4-[[4-[[4-(2-)-2,6-]]-2-]]
NO2014030I1 (no) (E)-4-[[4-[[4-(2-cyanoetenyl)-2,6-dimetylfenyl]-amino]-2-pyrimidinyl]-amino]-benzonitril("Rilpivirine") samt enhver terapeutisk form derav som er dekket av det aktuelle patentet så som farmasøytisk akseptable salter av Rilpivirie innbefattende hydrokloridsaltet av Rilpivirine, og emtricitabine.
AP1449A (en) Pharmaceutical compositions comprising a hmg reductase inhibitor.
PL1632232T3 (pl) Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu
EP1630157A4 (en) ANTAGONIST OF CASR
UA92467C2 (ru) Гидрохлорид 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила
WO2010030201A3 (en) Stable oral pharmaceutical composition containing a pharmaceutically acceptable salt of [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3r, 5s) - 3,5 dihydroxyhept-6- enoic acid
HK1112862A1 (sl)
HRP20110563T1 (en) Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile